• DEXLANSOPRAZOLE chembl:CHEMBL1201863 Approved

    Alternate Names:

    DEXLANSOPRAZOLE
    DEXILANT SOLUTAB
    TAK-390
    KAPIDEX
    DEXILANT
    T-168390
    LANSOPRAZOLE R-FORM
    DEXILANT®
    TAK 390
    (R)-LANSOPRAZOLE
    KAPIDEX®
    2-((R)-((3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)-2-PYRIDINYL)METHYL)SULFINYL)-1H-BENZIMIDAZOLE
    (+)-LANSOPRAZOL
    DEXILANT SOLUTAB®
    T 168390
    chemidplus:138530-94-6
    drugbank:05351
    pubchem.compound:9578005
    chembl:CHEMBL1201863
    rxcui:816346

    Drug Info:

    FDA Approval not approved
    Drug Class Small molecule
    Drug Indications Proton pump inhibitor
    (2 More Sources)
  • Interaction Score: 4.42

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Trial Name TAK-390MR, dexlansoprazole,Dexilant, Kapidex
    Novel drug target Established target
    Mechanism of Interaction Potassium-transporting ATPase inhibitor

    PMIDs:
    None found


  • Interaction Score: 2.06

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Potassium-transporting ATPase inhibitor

    PMIDs:
    None found


  • Interaction Score: 0.13

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22455762


    Sources:
    PharmGKB FDA